(Q54285333)
Statements
A randomised phase II study of irinotecan in combination with 5-FU/FA compared with irinotecan alone as second-line treatment of patients with metastatic colorectal carcinoma. (English)
Anke Reinacher-Schick
Wolff Schmiegel
Rainer Porschen
Ullrich Graeven
Theodor Heuer
Arnd Nusch
23 March 2007
30
4
169-174
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference